SCHEMBL19636934

SCHEMBL19636934

C=CCOC(=O)Nc1ccc(CNC(=O)c2cc(NC(=O)c3cc(NC(=O)c4nc(NC(=O)OC(C)(C)C)cn4C)cn3C)cn2C)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ERBB2 P04626 4/20 0.41
▸ HDAC1 Q13547 4/20 0.40
▸ HDAC2 Q92769 2/20 0.40
▸ HDAC8 Q9BY41 2/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.39
▸ NAMPT P43490 4/20 0.37
▸ MAPK14 Q16539 1/20 0.36
▸ MAPT P10636 3/20 0.36
▸ TDP1 Q9NUW8 3/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ XBP1 P17861 1/20 0.36
▸ GPR55 Q9Y2T6 1/20 0.36
▸ CYP17A1 P05093 1/20 0.35
▸ DRD2 P14416 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ F2 P00734 1/20 0.34
▸ F10 P00742 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19636845 0.99 ERBB2 (0.40) ERBB2HDAC1HDAC2HDAC8HDAC6
SCHEMBL19633223 0.91 NAMPT (0.43) HDAC1HDAC6NAMPTMAPK14MAPT
SCHEMBL25855374 0.90 ERBB2 (0.38) ERBB2HDAC1HDAC2HDAC8HDAC6
SCHEMBL19636936 0.86 ERBB2 (0.40) ERBB2HDAC1HDAC2HDAC8MAPT
SCHEMBL19633220 0.85 ERBB2 (0.40) ERBB2HDAC1HDAC2HDAC8MAPT
SCHEMBL30944502 0.85 NAMPT (0.42) NAMPTMAPK14MAPTCYP17A1DRD2
SCHEMBL30944532 0.85 NAMPT (0.42) NAMPTMAPK14MAPTCYP17A1DRD2
SCHEMBL19633089 0.84 ERBB2 (0.43) ERBB2HDAC1HDAC2HDAC8
SCHEMBL30046311 0.83 SMN1; SMN2 (0.37) ERBB2HDAC1HDAC2HDAC8MAPT
SCHEMBL19637500 0.83 ERBB2 (0.43) ERBB2HDAC1HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10660901-B2 Pyrrolobenzodiazepines and conjugates thereof MERSANA THERAPEUTICS, INC. (US) 2020-05-26 — — US disclosed
US-20190070194-A1 PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF MERSANA THERAPEUTICS, INC. 2019-03-07 — — US disclosed
US-20170333442-A1 PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF MERSANA THERAPEUTICS, INC. 2017-11-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170333442-A1 PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF CD79B, CLTB, FCGR3B ERBB2 65/4885HDAC1 1672/4885HDAC2 1196/4885
US-20190070194-A1 PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF CD79B, CLTB, FCGR3B ERBB2 65/4885HDAC1 1672/4885HDAC2 1196/4885
US-10660901-B2 Pyrrolobenzodiazepines and conjugates thereof CD79B, CLTB, FCGR3B ERBB2 65/4885HDAC1 1672/4885HDAC2 1196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback